Rogers H - Search Results

1

Allopurinol pharmacogenetics: assessment of potential clinical usefulness.

Zineh I, Mummaneni P, Lyndly J, Amur S, La Grenade LA, Chang SH, Rogers H, Pacanowski MA. Zineh I, et al. Among authors: rogers h. Pharmacogenomics. 2011 Dec;12(12):1741-9. doi: 10.2217/pgs.11.131. Pharmacogenomics. 2011. PMID: 22118056

2

CYP2D6 genotype information to guide pimozide treatment in adult and pediatric patients: basis for the U.S. Food and Drug Administration's new dosing recommendations.

Rogers HL, Bhattaram A, Zineh I, Gobburu J, Mathis M, Laughren TP, Pacanowski M. Rogers HL, et al. J Clin Psychiatry. 2012 Sep;73(9):1187-90. doi: 10.4088/JCP.11m07572. J Clin Psychiatry. 2012. PMID: 23059146

3

Consistency of drug-drug and gene-drug interaction information in US FDA-approved drug labels.

Conrado DJ, Rogers HL, Zineh I, Pacanowski MA. Conrado DJ, et al. Pharmacogenomics. 2013 Jan;14(2):215-23. doi: 10.2217/pgs.12.203. Pharmacogenomics. 2013. PMID: 23327581 Review.

4

How Informative Are Drug-Drug Interactions of Gene-Drug Interactions?

Lagishetty CV, Deng J, Lesko LJ, Rogers H, Pacanowski M, Schmidt S. Lagishetty CV, et al. Among authors: rogers h. J Clin Pharmacol. 2016 Oct;56(10):1221-31. doi: 10.1002/jcph.743. Epub 2016 Apr 26. J Clin Pharmacol. 2016. PMID: 27040602

5

Clinical and regulatory considerations in pharmacogenetic testing.

Schuck RN, Marek E, Rogers H, Pacanowski M. Schuck RN, et al. Among authors: rogers h. Am J Health Syst Pharm. 2016 Dec 1;73(23):1999-2006. doi: 10.2146/ajhp160476. Am J Health Syst Pharm. 2016. PMID: 27864207 Free PMC article. Review.

6

Considerations for Developing Targeted Therapies in Low-Frequency Molecular Subsets of a Disease.

Schuck RN, Woodcock J, Zineh I, Stein P, Jarow J, Temple R, Permutt T, LaVange L, Beaver JA, Charlab R, Blumenthal GM, Dorff SE, Leptak C, Lemery S, Rogers H, Chowdhury B, Litwack ED, Pacanowski M. Schuck RN, et al. Among authors: rogers h. Clin Pharmacol Ther. 2018 Aug;104(2):282-289. doi: 10.1002/cpt.1041. Epub 2018 Feb 23. Clin Pharmacol Ther. 2018. PMID: 29473145 Free PMC article. Review.

7

Clinical Pharmacology Studies Supporting Oligonucleotide Therapy Development: An Assessment of Therapies Approved and in Development Between 2012 and 2018.

Rogers H, Adeniyi O, Ramamoorthy A, Bailey S, Pacanowski M. Rogers H, et al. Clin Transl Sci. 2021 Mar;14(2):468-475. doi: 10.1111/cts.12945. Epub 2021 Jan 27. Clin Transl Sci. 2021. PMID: 33278337 Free PMC article. Review.

8

Clinical Pharmacology of RNA Interference-Based Therapeutics: A Summary Based on Food and Drug Administration-Approved Small Interfering RNAs.

Jing X, Arya V, Reynolds KS, Rogers H. Jing X, et al. Among authors: rogers h. Drug Metab Dispos. 2023 Feb;51(2):193-198. doi: 10.1124/dmd.122.001107. Epub 2022 Nov 4. Drug Metab Dispos. 2023. PMID: 36332914 Free PMC article. Review.

9

An integrated clinical pharmacology approach for deriving dosing recommendations in a regulatory setting: review of recent cases in psychiatry drugs.

Younis IR, Rogers H, Zhang H, Zhu H, Uppoor RS, Mehta MU. Younis IR, et al. Among authors: rogers h. J Clin Pharmacol. 2013 Oct;53(10):1005-9. doi: 10.1002/jcph.118. Epub 2013 Jul 10. J Clin Pharmacol. 2013. PMID: 23842865 Review.

10

The U.S. Food and Drug Administration's Experience with Ivacaftor in Cystic Fibrosis. Establishing Efficacy Using In Vitro Data in Lieu of a Clinical Trial.

Durmowicz AG, Lim R, Rogers H, Rosebraugh CJ, Chowdhury BA. Durmowicz AG, et al. Among authors: rogers h. Ann Am Thorac Soc. 2018 Jan;15(1):1-2. doi: 10.1513/AnnalsATS.201708-668PS. Ann Am Thorac Soc. 2018. PMID: 29020455

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,160 results

Search Page

Filters